These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27991921)

  • 1. ROCK2/ras
    Masre SF; Rath N; Olson MF; Greenhalgh DA
    Oncogene; 2017 May; 36(18):2529-2542. PubMed ID: 27991921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal ROCK2 induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin C; but enhanced differentiation and p53/p21 inhibit papilloma.
    Masre SF; Rath N; Olson MF; Greenhalgh DA
    Carcinogenesis; 2020 Oct; 41(10):1409-1420. PubMed ID: 31907522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3σ/Stratifin and p21 limit AKT-related malignant progression in skin carcinogenesis following MDM2-associated p53 loss.
    McMenemy CM; Guo D; Quinn JA; Greenhalgh DA
    Mol Carcinog; 2024 Sep; 63(9):1768-1782. PubMed ID: 38869281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
    Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
    Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.
    Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR
    Mol Carcinog; 1994 May; 10(1):15-22. PubMed ID: 8185825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis.
    Wang XJ; Greenhalgh DA; Donehower LA; Roop DR
    Mol Carcinog; 2000 Oct; 29(2):67-75. PubMed ID: 11074603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
    Wang XJ; Greenhalgh DA; Roop DR
    Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
    Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
    Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
    Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations for skin carcinogenesis experiments using inducible transgenic mouse models.
    Popis MC; Wagner RE; Constantino-Casas F; Blanco S; Frye M
    BMC Res Notes; 2018 Jan; 11(1):67. PubMed ID: 29361972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
    Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
    Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant Nrf2
    Witherspoon JG; Hall JR; Jima D; Atkins HM; Wamsley NT; Major MB; Weissman BE; Smart RC
    Redox Biol; 2024 Sep; 75():103261. PubMed ID: 38963974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas.
    Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR
    Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.